Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project.

Morbelli S, Drzezga A, Perneczky R, Frisoni GB, Caroli A, van Berckel BN, Ossenkoppele R, Guedj E, Didic M, Brugnolo A, Sambuceti G, Pagani M, Salmon E, Nobili F.

Neurobiol Aging. 2012 Nov;33(11):2533-50. doi: 10.1016/j.neurobiolaging.2012.01.005. Epub 2012 Feb 23.

PMID:
22365486
2.

Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease.

Fouquet M, Desgranges B, Landeau B, Duchesnay E, Mézenge F, de la Sayette V, Viader F, Baron JC, Eustache F, Chételat G.

Brain. 2009 Aug;132(Pt 8):2058-67. doi: 10.1093/brain/awp132. Epub 2009 May 28.

3.

Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer disease consortium project.

Morbelli S, Perneczky R, Drzezga A, Frisoni GB, Caroli A, van Berckel BN, Ossenkoppele R, Guedj E, Didic M, Brugnolo A, Naseri M, Sambuceti G, Pagani M, Nobili F.

J Nucl Med. 2013 Jun;54(6):894-902. doi: 10.2967/jnumed.112.113928. Epub 2013 Apr 16.

4.

Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.

Del Sole A, Clerici F, Chiti A, Lecchi M, Mariani C, Maggiore L, Mosconi L, Lucignani G.

Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1357-66. doi: 10.1007/s00259-008-0773-6. Epub 2008 Apr 17.

PMID:
18418593
5.

MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings.

Pagani M, Dessi B, Morbelli S, Brugnolo A, Salmaso D, Piccini A, Mazzei D, Villavecchia G, Larsson SA, Rodriguez G, Nobili F.

Curr Alzheimer Res. 2010 Jun;7(4):287-94.

PMID:
19939228
6.

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A.

Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. Epub 2003 May 23.

PMID:
12764551
7.

Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.

Ossenkoppele R, Zwan MD, Tolboom N, van Assema DM, Adriaanse SF, Kloet RW, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN.

Brain. 2012 Jul;135(Pt 7):2115-25. doi: 10.1093/brain/aws113. Epub 2012 May 3.

8.

Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.

Hunt A, Schönknecht P, Henze M, Seidl U, Haberkorn U, Schröder J.

Psychiatry Res. 2007 Jul 15;155(2):147-54. Epub 2007 May 23.

PMID:
17524628
9.

Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment.

Wu X, Chen K, Yao L, Ayutyanont N, Langbaum JB, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Foster NL, Thompson PM, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci Methods. 2010 Oct 15;192(2):277-85. doi: 10.1016/j.jneumeth.2010.07.030. Epub 2010 Aug 1.

10.

Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease.

Chételat G, Desgranges B, Landeau B, Mézenge F, Poline JB, de la Sayette V, Viader F, Eustache F, Baron JC.

Brain. 2008 Jan;131(Pt 1):60-71. Epub 2007 Dec 5.

11.

Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.

Küntzelmann A, Guenther T, Haberkorn U, Essig M, Giesel F, Henze R, Schroeter ML, Schröder J, Schönknecht P.

Neurosci Lett. 2013 Feb 8;534:12-7. doi: 10.1016/j.neulet.2012.11.026. Epub 2012 Nov 23.

PMID:
23182881
12.

Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.

Roy K, Pepin LC, Philiossaint M, Lorius N, Becker JA, Locascio JJ, Rentz DM, Sperling RA, Johnson KA, Marshall GA.

J Alzheimers Dis. 2014;42(1):291-300. doi: 10.3233/JAD-131796.

13.

Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease.

Mosconi L, Pupi A, De Cristofaro MT, Fayyaz M, Sorbi S, Herholz K.

J Nucl Med. 2004 Mar;45(3):382-92.

14.

Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.

Habeck C, Risacher S, Lee GJ, Glymour MM, Mormino E, Mukherjee S, Kim S, Nho K, DeCarli C, Saykin AJ, Crane PK; Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2012 Dec;6(4):568-83. doi: 10.1007/s11682-012-9208-x.

15.

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.

Brain. 2006 Nov;129(Pt 11):2856-66. Epub 2006 Jul 19.

16.

Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.

Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marcone A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D.

Arch Neurol. 2005 Nov;62(11):1728-33.

PMID:
16286547
17.

Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.

Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, Heumann M, Wernette K.

Exp Neurol. 2005 Feb;191 Suppl 1:S95-S103.

PMID:
15629765
18.

Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies.

Ishii K, Sasaki H, Kono AK, Miyamoto N, Fukuda T, Mori E.

Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):959-63. Epub 2005 Mar 31.

PMID:
15800784
19.

Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.

Furukawa K, Okamura N, Tashiro M, Waragai M, Furumoto S, Iwata R, Yanai K, Kudo Y, Arai H.

J Neurol. 2010 May;257(5):721-7. doi: 10.1007/s00415-009-5396-8. Epub 2009 Nov 28.

PMID:
19946781
20.

Unawareness of memory deficit in amnestic MCI: FDG-PET findings.

Nobili F, Mazzei D, Dessi B, Morbelli S, Brugnolo A, Barbieri P, Girtler N, Sambuceti G, Rodriguez G, Pagani M.

J Alzheimers Dis. 2010;22(3):993-1003. doi: 10.3233/JAD-2010-100423.

PMID:
20858977
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk